The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism
Open accessAbstract
of recommendations Clinical• All patients with possible PE should have clinical probability assessed and documented.[C] • An alternative clinical explanation should always be considered at presentation and sought when PE is excluded.[C] D-dimer • Blood D-dimer assay should only be considered following assessment of clinical probability.[B] • D-dimer assay should not be performed in those with high clinical probability of PE. [B] • A negative D-dimer test reliably excludes PE in patients with low (SimpliRED, Vidas, MDA) or intermediate (Vidas, MDA) clinical probability; such patients do not require imaging for VTE.[B] • Each hospital should provide information on sensitivity and specificity of its D-dimer test.[C] Imaging • CTPA is now the recommended initial lung imaging modality for non-massive PE. [B] • Patients with a good quality negative CTPA do not require further investigation or treatment for PE.[A] • Isotope lung scanning may be considered as the initial imaging investigation providing (a) facilities are available on site, and (b) chest radiograph is normal, and (c) there is no significant symptomatic concurrent cardiopulmonary disease, and (d) standardised reporting criteria are used, and (e) a non-diagnostic result is always followed by further imaging.[B] • Where isotope lung scanning is normal, PE is reliably excluded [B] but a significant minority of high probability results are false positive.[B] • In patients with coexisting clinical DVT, leg ultrasound as the initial imaging test is often sufficient to confirm VTE.[B] • A single normal leg ultrasound should not be relied on for exclusion of subclinical DVT.[B] Massive PE • CTPA or echocardiography will reliably diagnose clinically massive PE. [B] • Thrombolysis is the first line treatment for massive PE [B] and may be instituted on clinical grounds alone if cardiac arrest is imminent [B]; a 50 mg bolus of alteplase is recommended.[C] • Invasive approaches (thrombus fragmentation and IVC filter insertion) should be considered where facilities and expertise are readily available.[C] Treatment • Thrombolysis should not be used as first line treatment in non-massive PE. [B] • Heparin should be given to patients with intermediate or high clinical probability before imaging.[C] • Unfractionated heparin (UFH) should be considered (a) as a first dose bolus, (b) in massive PE, or (c) where rapid reversal of effect may be needed.[C] • Otherwise, low molecular weight heparin (LMWH) should be considered as preferable to UFH, having equal efficacy and safety and being easier to use.[A] • Oral anticoagulation should only be commenced once VTE has been reliably confirmed.[C] • The target INR should be 2.0-3.0;when this is achieved, heparin can be discontinued.[A] • The standard duration of oral anticoagulation is: 4-6 weeks for temporary risk factors [A], 3 months for first idiopathic [A], and at least 6 months for other [C]; the risk of bleeding should be balanced with that of further VTE.[C]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goldhaber, S. Z., Visani, L., & De Rosa, M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07534-5 · Cited by 2,870
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., & Deykin, D. (2001) · Chest · doi:10.1378/chest.119.1_suppl.8s · Cited by 1,804
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380701 · Cited by 1,702
Anderson, D., Rodger, M., Ginsberg, J., Kearon, C., Gent, M., Turpie, A., Bormanis, J., Weitz, J., Chamberlain, M., Bowie, D., et al. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613830 · Cited by 1,659
A new system for grading recommendations in evidence based guidelines
Harbour, R., & Miller, J. (2001) · BMJ · doi:10.1136/bmj.323.7308.334 · Cited by 1,637
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Venous thrombosis: a multicausal disease
Rosendaal, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10266-0 · Cited by 1,576
Cited by
Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Derivation and validation of a prognostic model for pulmonary embolism
Aujesky, D., Obrosky, D. S., Stone, R. A., Auble, T. E., Perrier, A., Cornuz, J., Roy, P.-M., & Fine, M. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-862oc · Cited by 1,303
Prediction of Pulmonary Embolism in the Emergency Department: The Revised Geneva Score
Le Gal, G., Righini, M., Roy, P.-M., Sanchez, O., Aujesky, D., Bounameaux, H., & Perrier, A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00004 · Cited by 1,121
Time Trends in Pulmonary Embolism in the United States: Evidence of Overdiagnosis
Wiener, R. S., Schwartz, L. M., & Woloshin, S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.178 · Cited by 651
Multidetector-Row Computed Tomography in Suspected Pulmonary Embolism
Perrier, A., Roy, P.-M., Sanchez, O., Le Gal, G., Meyer, G., Gourdier, A.-L., Furber, A., Revel, M.-P., Howarth, N., Davido, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042905 · Cited by 642
Aujesky, D., Roy, P.-M., Verschuren, F., Righini, M., Osterwalder, J., Egloff, M., Renaud, B., Verhamme, P., Stone, R. A., Legall, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60824-6 · Cited by 598
Radiation Exposure and Pregnancy: When Should We Be Concerned?
McCollough, C. H., Schueler, B. A., Atwell, T. D., Braun, N. N., Regner, D. M., Brown, D. L., & LeRoy, A. J. (2007) · RadioGraphics · doi:10.1148/rg.274065149 · Cited by 570
Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
Shovlin, C. L. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.07.001 · Cited by 502
Hereditary haemorrhagic telangiectasia: a clinical and scientific review
Govani, F. S., & Shovlin, C. L. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.35 · Cited by 491
Acute Pulmonary Embolism: Part I: Epidemiology, Pathophysiology, and Diagnosis
Goldhaber, S. Z., & Elliott, C. G. (2003) · Circulation · doi:10.1161/01.cir.0000097829.89204.0c · Cited by 406
D‐Dimer for venous thromboembolism diagnosis: 20 years later
RIGHINI, M., PERRIER, A., DE MOERLOOSE, P., & BOUNAMEAUX, H. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02981.x · Cited by 374
Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism
van der Pol, L. M., Tromeur, C., Bistervels, I. M., Ni Ainle, F., van Bemmel, T., Bertoletti, L., Couturaud, F., van Dooren, Y. P. A., Elias, A., Faber, L. M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813865 · Cited by 359
Appropriateness of Diagnostic Management and Outcomes of Suspected Pulmonary Embolism
Roy, P.-M., Meyer, G., Vielle, B., Le Gall, C., Verschuren, F., Carpentier, F., Leveau, P., Furber, A., & for the EMDEPU Study Group* (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00003 · Cited by 324
Pulmonary embolism in pregnancy
Bourjeily, G., Paidas, M., Khalil, H., Rosene-Montella, K., & Rodger, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)60996-x · Cited by 306
Binder, L., Pieske, B., Olschewski, M., Geibel, A., Klostermann, B., Reiner, C., & Konstantinides, S. (2005) · Circulation · doi:10.1161/circulationaha.105.552216 · Cited by 304
A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS)*
Singh, S., McGlennan, A., England, A., & Simons, R. (2012) · Anaesthesia · doi:10.1111/j.1365-2044.2011.06896.x · Cited by 276
Validation of a model to predict adverse outcomes in patients with pulmonary embolism
Aujesky, D., Roy, P.-M., Le Manach, C. P., Verschuren, F., Meyer, G., Obrosky, D. S., Stone, R. A., Cornuz, J., & Fine, M. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi588 · Cited by 274
Guidelines on the use and monitoring of heparin
Baglin, T., Barrowcliffe, T. W., Cohen, A., Greaves, M., & the British Committee for Standards in Haematology (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05953.x · Cited by 262
Wiener, R. S., Schwartz, L. M., & Woloshin, S. (2013) · BMJ · doi:10.1136/bmj.f3368 · Cited by 259
Time Trends In Pulmonary Embolism In The United States: Evidence Of Overdiagnosis?
Wiener, R., Schwartz, L., & Woloshin, S. (2010) · D14. INNOVATIVE HEALTH SERVICES RESEARCH TO IMPROVE OUTCOMES · doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5348 · Cited by 256
Erez, O., Novack, L., Beer-Weisel, R., Dukler, D., Press, F., Zlotnik, A., Than, N. G., Tomer, A., & Mazor, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093240 · Cited by 146
Otero, R., Trujillo-Santos, J., Cayuela, A., Rodríguez, C., Barron, M., Martín, J. J., & Monreal, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00071007 · Cited by 74
Lin, B. W., Schreiber, D. H., Liu, G., Briese, B., Hiestand, B., Slattery, D., Kline, J. A., Goldhaber, S. Z., & Pollack, C. V. (2012) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2012.02.012 · Cited by 68
Oral anticoagulation strategies after a first idiopathic venous thromboembolic event
Aujesky, D., Smith, K. J., & Roberts, M. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.018 · Cited by 29
Metadata
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2003-06-01
- Volume
- 58
- Issue
- 6
- Pages
- 470-483
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W4232809868
- Cited by
- 686
- References
- 151
- FWCI
- 24.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.